Skip to main content

Table 2 Outcomes of IVF/ICSI cycles in women of advanced reproductive age (≥ 40 years old)

From: The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age

  

Serum AMH tertiles (ng/mL)

 

Total subjects

Low

(≤ 0.48)

Middle

(0.49~1.22)

High

(≥ 1.23)

Total cycle

116

21

38

57

Cancelled cycle (%)

17 (14.7)

10 (47.6)§

6 (15.7)*

1 (1.7)

Mean age

41.5 ± 1.4

42.8 ± 2.3

41.1 ± 1.3

41.3 ± 1.4

Peak E2 level (pg/mL)

1542.1 ± 1146.5

802.6 ± 748.9

1050 ± 699

2095.8 ± 1156.2

Number of oocytes retrieved

6.1 ± 4.6

2.4 ± 2.9

4.7 ± 2.5

8.1 ± 5.1

Number of mature oocytes

4.7 ± 3.7

1.5 ± 1.73

3.9 ± 2.5

6.3 ± 3.9

Embryos obtained

3.8 ± 2.9

1.8 ± 2.4

3.1 ± 2.2

4.8 ± 3.1

Embryos transferred

2.8 ± 1.2

1.6 ± 1.3

2.6 ± 1.0

3.2 ± 1.0

Clinical pregnancy per cycle (%)

26 (22.4)

0 (0)§

9 (23.7)

17 (29.8)

Abortion per cycle (%)

7 (26.9)

0 (0)

0 (0)

7 (41.2)

Viable pregnancy per cycle (%) [FHB (+) & > 7 wks.]

19 (16.4)

0 (0)

9 (23.7)

10 (17.5)

  1. § p < 0.05 compared with the middle tertile and the high tertile
  2. *p < 0.05 compared with the high tertile
  3. p < 0.05 compared with the middle tertile